Učitavanje...

Clinical development of novel proteasome inhibitors for cancer treatment

BACKGROUND: Emerging evidence demonstrates that targeting the tumor proteasome is a promising strategy for cancer therapy. OBJECTIVE: This review summarizes recent results from cancer clinical trials using specific proteasome inhibitors or some natural compounds that have proteasome-inhibitory effec...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Yang, Huanjie, Zonder, Jeffrey A, Dou, Q Ping
Format: Artigo
Jezik:Inglês
Izdano: 2009
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3758888/
https://ncbi.nlm.nih.gov/pubmed/19505187
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/13543780903002074
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!